Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Could a simple gel replace surgery for HPV-Related cervical changes?

NCT ID NCT05509413

First seen Nov 18, 2025 · Last updated Jun 23, 2026 · Updated 30 times

Summary

This study tested whether a vaginal gel called DEFLAGYN, made from silica and citric acid, can help women with unclear cervical smears and high-risk HPV infections clear the virus and avoid surgery. 242 women used the gel for 3 months. The goal was to see if the gel increases the rate of HPV clearance and regression of abnormal cells compared to waiting without treatment.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HPV INFECTION are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • Marien Hospital Herne

    Herne, North Rhine-Westphalia, 44625, Germany

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

DEFLAGYN vaginal gel (silica and citric acid)

What this could lead to

If it works, this could offer a non-surgical, wait-and-see option for women with unclear cervical smears and high-risk HPV, potentially reducing the need for procedures like conization.

What could go wrong

This is a completed study with limited prior evidence. The gel is a medical device, not a drug, and its effect may be modest. Side effects were not observed in a prior small trial, but larger studies are needed to confirm benefits.

Conditions

The condition(s) this trial relates to.

cervical intraepithelial neoplasia dysplasia of cervix human papilloma virus infection

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.